Thrombotic Thrombocytopenic Purpura

As per available reports about 94 journals, 330 Conferences are presently dedicated exclusively to Thrombotic thrombocytopenic purpura & other Blood disorders and about 37900 articles are being published on the current research in Thrombotic thrombocytopenic purpura. In terms of research annually, USA, India, Japan, Brazil and Canada are some of the leading countries where maximum studies related to Thrombotic thrombocytopenic purpura and other Blood disorders are being carried out. As reported in Thrombotic thrombocytopenic purpura or Moschcowitz syndrome by Bellucci et al., Thrombotic thrombocytopenic purpura is a rare disorder with a poor prognosis. It is a rare disorder of the blood-coagulation system, causing extensive microscopic clots to form in the small blood vessels throughout the body. This syndrome is characterized by a microangiopathic hemolytic anemia with thrombocytopenia, neurologic symptoms and renal disease.

The Journal of Blood Disorders & Transfusion is an academic journal – hosted by OMICS International – a pioneer in open access publishing–and is listed among the top 10 journals on Thrombotic thrombocytopenic purpura & other Blood disorders. Each year research scientists have noticed a rise in the number of congresses being held in this field. The Journal of Blood Disorders & Transfusion provides a unique platform to researchers and scientist to explore the advanced and latest research developments in the field Thrombotic thrombocytopenic purpura and other Blood disorders, thus bridging the gap between researchers and young scientists.

OMICS Group organizing 2^ndInternational Conference on Hematology & Blood Disorders with the theme “On the Path of Identifying Novel Therapeutics for Blood Disorders” with a well reputed organizing committee during Sep 29- Oct 01, 2014 at Baltimore, USA